Study finds further evidence of the ‘European Paradox’ and the failure to translate excellent research towards the market
Photo credits: Varavin88 / BigStock
Companies in the US are the biggest commercial winners from the European Research Council (ERC), patenting far more products based on the science it funds than European companies or universities, according to a new study.
The findings, which the ERC says confirm its own internal research, are the latest to show Europe is not translating good basic science into real world innovation.
“In absolute terms […] US organisations, especially US companies, still lead in deriving the greatest benefits from ERC science,” concludes the study published in the journal Research Policy.
The ERC, founded in 2007, has a €16 billion budget in the period 2021-27, and aims to give academics some of the world’s most generous,…
Discover the latest in research funding every Tuesday with Funding Newswire. Dive into detailed articles with our monthly or yearly subscriptions or start with a free trial
NOTE: if you're a part of one of our Network member organisations, you get free access by signing up with your institutional email. Verify your eligibility here.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.